Skip to main content

Table 1 Baseline characteristics of the enrolled patients in each group

From: Comparison of statin plus ezetimibe with double-dose statin on lipid profiles and inflammation markers

 

A20E10 (n = 48)

A40 (n = 50)

P value

Age(yrs)

56 ± 11

57 ± 8

0.6014

Male/Female

35/13

36/14

0.8207

TC(mmol/L)

4.91 ± 0.95

4.82 ± 0.73

0.645

TG(mmol/L)

1.89 ± 0.73

1.74 ± 0.79

0.332

HDL-C(mmol/L)

1.07 ± 0.25

1.14 ± 0.31

0.195

LDL-C(mmol/L)

3.31 ± 0.89

3.20 ± 0.90

0.540

Non-HDL-C(mmol/L)

3.91 ± 0.91

3.56 ± 0.78

0.077

Lp(a) (mg/L)

222 ± 215

160 ± 195

0.140

ApoB(mmol/L)

1.09 ± 0.29

1.10 ± 0.26

0.774

Apa A1(mmol/L)

1.30 ± 0.33

1.45 ± 0.45

0.063

ALT(U/L)

23.44 ± 15.36

19.90 ± 10.84

0.190

AST(U/L)

19.89 ± 5.99

17.80 ± 6.02

0.089

TBil(umol/L)

14.26 ± 4.19

13.96 ± 4.28

0.722

DBil(umol/L)

2.30 ± 0.64

2.34 ± 0.71

0.748

Cr(umol/L)

77.69 ± 15.57

73.36 ± 14.79

0.163

BUN(mmol/L)

5.05 ± 1.07

5.28 ± 1.16

0.327

CK(U/L)

82.13 ± 35.11

107.60 ± 117.44

0.157

FBG(mmol/L)

5.34 ± 1.00

5.76 ± 1.24

0.075

HsCRP(mg/dL)

1.74 ± 1.97

2.45 ± 3.00

0.178

ox-LDL(U/L)

6.04 ± 2.00

6.04 ± 2.00

0.998

  1. Notes: TC Total cholesterol, TG Triglyceride, HDL-C High-density lipoprotein cholesterol, LDL-C Low-density lipoprotein cholesterol, Lp(a) Lipoprotein a, ApoB Apolipoprotein B, ApoAI ApolipoproteinAI, ALT Alanine aminotransferase, AST Aspartate Transaminase, TBil Total Bilirubin, DBil Direct Bilirubin, Cr Creatinine, CK Creatine Kinase, UA Uric Acid, FBG Fasting Blood Glucose, HsCRP High sensitive C- Reactive Protein, ox-LDL oxidation low-density lipoprotein
  2. A20E10 indicates the patients who received Atorvastatin 20 mg qn plus Ezetimibe 10 mg qd,A40 indicates the patients who received Atorvastatin 40 mg qn